They are indicated for adults with relapsing forms of MS. In the end, starting and sticking to a DMT—even if you have to ...

The Multiple Sclerosis Treatment Optimization Program (MSTOP) was motivated by research showing that Black and Hispanic ...

19 The first oral treatment, fingolimod, was introduced in 2010; it is also the only DMT approved for the treatment of MS in pediatric patients aged over 10 years. 19,22 Fingolimod is an analogue ...

Biogen’s commitment to MS management extends beyond understanding the pathogenic role of CNS-targeted autoimmunity and traditional DMT research to fostering innovative treatment initiatives ...

The Patient-Centered Outcomes Research Institute (PCORI) gave the Cleveland Clinic $6.7 million to identify optimal RRMS ...

MS patients in the U.S. with Medicaid coverage have worse disease outcomes compared with those who have private insurance, a new study found.

For more information, visit our medical review board. Reviewed by Jennifer Giuglianotti, MS, BC-DMT, LCAT, board certified dance/movement therapist, licensed creative arts therapist, and owner of ...